Moreover, not all Union imports of medical devices originating in the PRC would fall within the scope of the IPI measure. Publicly available data from the Union industry show that public procurement accounts for only 50 % to 70 % of the total Union market for medical devices. If it is assumed that public procurement of medical devices originating in the PRC would account for a similar share (i.e. between EUR 3 and 4,5 billion), combined with the fact that 41 % of the Union public procurement procedures for medical devices would not be subject to the IPI measure [As they would fall below the EUR 5000000 net of VAT threshold set in Article 6(4) of the IPI Regulation.], the value of medical devices originating in the PRC that would potentially need to be procured from alternative sources of supply, would be much smaller than the total value of Union imports of medical devices from the PRC.
41 2. DETERMINATION OF THE IPI MEASURE › 2.2. Availability of alternative sources of supply, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025